Axonius raised €18M in a Series B round in Jul 2019. The company is based in Tel Aviv, Israel. Investors in the round: OpenView Venture Partners. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
